MOMETASONE FUROATE MONOHYDRATE

MOMETASONE FUROATE MONOHYDRATE was reported 510 times

MOMETASONE FUROATE MONOHYDRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 2 1 0.1111
1 THROMBOPHLEBITIS SEPTIC 5 0.0244
2 THORACIC SPINAL STENOSIS 1 0.0238
3 HEREDITARY DISORDER 1 0.0175
4 SPOUSAL ABUSE 1 0.0120
5 APPLICATION SITE COLDNESS 1 0.0118
6 BIOPSY BREAST ABNORMAL 1 0.0105
7 ORAL LICHENOID REACTION 1 0.0092
8 PITUITARY CYST 1 0.0090
9 PROGRESSIVE RELAPSING MULTIPLE SCLEROSIS 1 0.0081
10 ENTHESOPATHY 12 0.0077
11 SYRINGOMYELIA 2 0.0072
12 VAGINAL CONTRACEPTIVE DEVICE EXPELLED 1 0.0071
13 MOUTH BREATHING 3 0.0069
14 EXPOSURE TO TOXIC AGENT 22 0.0069
15 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 1 0.0056
16 LICHENIFICATION 2 0.0049
17 BREAST NECROSIS 1 0.0048
18 DISSOCIATIVE IDENTITY DISORDER 1 0.0048
19 TENOSYNOVITIS 12 0.0043
20 PERIPHERAL VEIN THROMBOSIS 1 0.0042
21 STOMA SITE ABSCESS 1 0.0041
22 ARTERIAL THERAPEUTIC PROCEDURE 1 0.0041
23 IATROGENIC INJURY 5 0.0039
24 BLOOD CHOLINESTERASE DECREASED 1 0.0036
25 HYPNAGOGIC HALLUCINATION 1 0.0033
26 LACUNAR STROKE 1 0.0031
27 HEMIHYPOAESTHESIA 1 0.0028
28 ENDOMETRIAL ABLATION 1 0.0028
29 INFECTION IN AN IMMUNOCOMPROMISED HOST 2 0.0028
30 TOOTH REPAIR 1 0.0028
31 SUSPECTED PRODUCT QUALITY ISSUE 5 0.0027
32 BENIGN NEOPLASM OF THYROID GLAND 2 0.0027
33 POLYCYSTIC OVARIAN SYNDROME 1 0.0026
34 BONE DENSITY INCREASED 1 0.0025
35 MIXED CONNECTIVE TISSUE DISEASE 1 0.0024
36 PRODUCT WITH QUALITY ISSUE ADMINISTERED 1 0.0022
37 HEPATIC ENZYME DECREASED 1 0.0022
38 MONONEUROPATHY MULTIPLEX 1 0.0022
39 ARNOLD-CHIARI MALFORMATION 2 0.0021
40 BRAIN ABSCESS 5 0.0020
41 BRAIN SCAN ABNORMAL 1 0.0018
42 MONOCLONAL GAMMOPATHY 1 0.0016
43 FASCIITIS 1 0.0015
44 MAMMOGRAM ABNORMAL 1 0.0015
45 STASIS DERMATITIS 1 0.0015
46 BUNION 1 0.0014
47 PARASOMNIA 1 0.0014
48 LIPIDS ABNORMAL 1 0.0014
49 FIBROCYSTIC BREAST DISEASE 1 0.0014
50 SIMPLE PARTIAL SEIZURES 1 0.0012
51 PITUITARY TUMOUR BENIGN 2 0.0012
52 ARTERIOVENOUS MALFORMATION 1 0.0011
53 CONTRAST MEDIA ALLERGY 2 0.0011
54 PHARYNGEAL HYPOAESTHESIA 1 0.0011
55 SERUM SICKNESS 3 0.0011
56 SNORING 4 0.0011
57 NASAL SEPTUM DEVIATION 2 0.0010
58 HAEMANGIOMA OF LIVER 1 0.0010
59 BURSITIS 12 0.0010
60 AUTONOMIC NEUROPATHY 1 0.0010
61 BREAST NEOPLASM 1 0.0010
62 AXILLARY MASS 1 0.0010
63 PRE-EXISTING CONDITION IMPROVED 6 0.0010
64 BINGE EATING 1 0.0009
65 RHINITIS ALLERGIC 4 0.0009
66 DRUG EFFECT VARIABLE 1 0.0009
67 MOANING 1 0.0009
68 CARBON DIOXIDE DECREASED 1 0.0009
69 ACUTE LUNG INJURY 1 0.0008
70 LABILE BLOOD PRESSURE 1 0.0008
71 BILE DUCT STENOSIS 1 0.0008
72 PROSTATIC OPERATION 1 0.0008
73 CHRONIC RESPIRATORY FAILURE 1 0.0008
74 CEREBRAL ARTERY EMBOLISM 1 0.0008
75 AORTIC VALVE REPLACEMENT 1 0.0008
76 HYPOVITAMINOSIS 1 0.0008
77 AREFLEXIA 2 0.0007
78 CHONDROPATHY 2 0.0007
79 PHARYNGEAL DISORDER 2 0.0007
80 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
81 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
82 BRAIN HERNIATION 2 0.0007
83 MYOGLOBIN BLOOD INCREASED 1 0.0007
84 POLYCYSTIC OVARIES 1 0.0006
85 VIRAL UPPER RESPIRATORY TRACT INFECTION 3 0.0006
86 RASH VESICULAR 3 0.0006
87 GASTROINTESTINAL OEDEMA 1 0.0006
88 STRESS FRACTURE 3 0.0006
89 BODY TEMPERATURE ABNORMAL 1 0.0005
90 ORAL PAIN 12 0.0005
91 NASAL OBSTRUCTION 1 0.0005
92 BILE DUCT OBSTRUCTION 1 0.0005
93 SPINAL CORD COMPRESSION 2 0.0005
94 HYPOGEUSIA 1 0.0005
95 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
96 LIBIDO INCREASED 1 0.0005
97 RENAL HAEMORRHAGE 1 0.0005
98 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 1 0.0005
99 TRIGGER FINGER 2 0.0005
100 CHEST INJURY 1 0.0005
101 MEDICAL DEVICE PAIN 1 0.0005
102 ABSCESS INTESTINAL 1 0.0005
103 APPLICATION SITE SCAB 1 0.0005
104 MIDDLE EAR EFFUSION 1 0.0005
105 ACCIDENT AT WORK 1 0.0005
106 PRODUCT LOT NUMBER ISSUE 1 0.0005
107 NECK SURGERY 1 0.0004
108 SPINAL COLUMN STENOSIS 2 0.0004
109 URINARY HESITATION 1 0.0004
110 BRONCHITIS CHRONIC 1 0.0004
111 DERMAL CYST 1 0.0004
112 HEART INJURY 1 0.0004
113 LACTOSE INTOLERANCE 1 0.0004
114 FOETAL DEATH 2 0.0004
115 PERIORBITAL OEDEMA 2 0.0004
116 PRODUCT ODOUR ABNORMAL 4 0.0004
117 NASAL DISORDER 1 0.0004
118 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
119 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
120 BRUXISM 2 0.0004
121 HYDROCEPHALUS 2 0.0004
122 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
123 CHOLECYSTITIS ACUTE 2 0.0004
124 RESPIRATORY SYMPTOM 1 0.0004
125 FIBULA FRACTURE 1 0.0003
126 PARAPLEGIA 1 0.0003
127 HYPERTONIC BLADDER 1 0.0003
128 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
129 LUMBAR SPINAL STENOSIS 1 0.0003
130 ATYPICAL PNEUMONIA 1 0.0003
131 LOSS OF EMPLOYMENT 1 0.0003
132 DYSAESTHESIA 1 0.0003
133 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
134 INJECTION SITE HYPERSENSITIVITY 1 0.0003
135 ABDOMINAL ADHESIONS 1 0.0003
136 IRIDOCYCLITIS 1 0.0003
137 DYSGRAPHIA 2 0.0003
138 OTITIS MEDIA 1 0.0003
139 PLANTAR FASCIITIS 1 0.0003
140 NEOPLASM RECURRENCE 1 0.0003
141 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
142 TACHYPHRENIA 1 0.0003
143 THROMBOPHLEBITIS 1 0.0003
144 BODY HEIGHT DECREASED 3 0.0003
145 SKIN WEEPING 1 0.0003
146 PARAESTHESIA ORAL 4 0.0003
147 THROAT CLEARING 1 0.0003
148 CHRONIC SINUSITIS 1 0.0003
149 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
150 FAECES HARD 1 0.0003
151 NASAL DISCOMFORT 2 0.0003
152 MIOSIS 2 0.0002
153 ENURESIS 1 0.0002
154 FRUSTRATION TOLERANCE DECREASED 2 0.0002
155 APPLICATION SITE EXFOLIATION 1 0.0002
156 MENSTRUAL DISORDER 2 0.0002
157 ONYCHOMADESIS 1 0.0002
158 SENSATION OF FOREIGN BODY 2 0.0002
159 CARDIAC FAILURE CHRONIC 1 0.0002
160 LUNG NEOPLASM 1 0.0002
161 PURULENT DISCHARGE 1 0.0002
162 VITAMIN D DECREASED 2 0.0002
163 MUSCLE STRAIN 2 0.0002
164 GRIP STRENGTH DECREASED 2 0.0002
165 ABDOMINAL HERNIA 1 0.0002
166 ISCHAEMIA 1 0.0002
167 RENAL FUNCTION TEST ABNORMAL 1 0.0002
168 GASTRITIS EROSIVE 1 0.0002
169 PERFORMANCE STATUS DECREASED 1 0.0002
170 MIDDLE INSOMNIA 4 0.0002
171 YELLOW SKIN 1 0.0002
172 SEASONAL ALLERGY 3 0.0002
173 SKIN ABRASION 1 0.0002
174 SLEEP APNOEA SYNDROME 4 0.0002
175 FAECAL INCONTINENCE 1 0.0002
176 HORMONE LEVEL ABNORMAL 1 0.0002
177 HYPERNATRAEMIA 1 0.0002
178 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
179 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
180 STOMATITIS 12 0.0002
181 INITIAL INSOMNIA 2 0.0002
182 INCREASED UPPER AIRWAY SECRETION 1 0.0002
183 TRISMUS 1 0.0002
184 STOMACH DISCOMFORT 1 0.0002
185 PNEUMOTHORAX 3 0.0002
186 PHARYNGOLARYNGEAL PAIN 1 0.0002
187 ANORECTAL DISCOMFORT 1 0.0002
188 FOOD POISONING 1 0.0002
189 PAIN OF SKIN 5 0.0002
190 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
191 GENERALISED ERYTHEMA 1 0.0002
192 BLOOD IRON DECREASED 2 0.0002
193 THIRST 3 0.0002
194 CARDIAC PACEMAKER INSERTION 1 0.0002
195 FIBROMYALGIA 4 0.0002
196 VULVOVAGINAL BURNING SENSATION 1 0.0002
197 MENISCUS INJURY 1 0.0002
198 MUSCULOSKELETAL STIFFNESS 14 0.0002
199 FEELING JITTERY 3 0.0002
200 ROTATOR CUFF SYNDROME 2 0.0002
201 GALACTORRHOEA 1 0.0002
202 HERNIA 3 0.0002
203 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
204 CARDIAC FLUTTER 1 0.0002
205 INCOHERENT 1 0.0002
206 EAR PAIN 3 0.0002
207 HYPERPROLACTINAEMIA 1 0.0002
208 CHOKING 3 0.0002
209 NASAL CONGESTION 9 0.0002
210 SOMNAMBULISM 1 0.0002
211 TOOTH INFECTION 2 0.0002
212 UPPER LIMB FRACTURE 3 0.0002
213 MENINGITIS 1 0.0001
214 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
215 POST-TRAUMATIC STRESS DISORDER 1 0.0001
216 SINUSITIS 15 0.0001
217 APPLICATION SITE RASH 2 0.0001
218 PALPITATIONS 17 0.0001
219 HAIR GROWTH ABNORMAL 1 0.0001
220 LARGE INTESTINE POLYP 1 0.0001
221 HUNGER 2 0.0001
222 APPLICATION SITE REACTION 1 0.0001
223 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
224 POOR QUALITY SLEEP 3 0.0001
225 TONGUE DISORDER 1 0.0001
226 HYPOKINESIA 2 0.0001
227 UTERINE LEIOMYOMA 1 0.0001
228 PSYCHIATRIC SYMPTOM 1 0.0001
229 TOOTH DISORDER 3 0.0001
230 FEELING HOT 8 0.0001
231 FEMUR FRACTURE 4 0.0001
232 PELVIC FRACTURE 1 0.0001
233 MULTIPLE ALLERGIES 1 0.0001
234 DRUG SCREEN POSITIVE 1 0.0001
235 FURUNCLE 1 0.0001
236 DISORIENTATION 5 0.0001
237 NIGHT SWEATS 4 0.0001
238 MUSCLE TIGHTNESS 2 0.0001
239 RHEUMATOID ARTHRITIS 14 0.0001
240 BACK DISORDER 2 0.0001
241 INJECTION SITE URTICARIA 3 0.0001
242 HEMIPLEGIA 1 0.0001
243 EYE PRURITUS 4 0.0001
244 FACIAL PARALYSIS 1 0.0001
245 PSYCHOLOGICAL TRAUMA 1 0.0001
246 MIGRAINE 11 0.0001
247 ASTHMA 13 0.0001
248 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
249 APPLICATION SITE ERYTHEMA 3 0.0001
250 SPINAL OSTEOARTHRITIS 1 0.0001
251 FACIAL PAIN 1 0.0001
252 THROAT IRRITATION 5 0.0001
253 ANAL INCONTINENCE 1 0.0001
254 THROAT TIGHTNESS 3 0.0001
255 GASTROENTERITIS VIRAL 2 0.0001
256 OPTIC NEURITIS 1 0.0001
257 EXOSTOSIS 1 0.0001
258 BRAIN NEOPLASM 1 0.0001
259 NERVE COMPRESSION 1 0.0001
260 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
261 SQUAMOUS CELL CARCINOMA 1 0.0001
262 SPUTUM DISCOLOURED 1 0.0001
263 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
264 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
265 AFFECT LABILITY 1 0.0001
266 PRESCRIBED OVERDOSE 2 0.0001
267 DYSSTASIA 3 0.0001
268 VITAMIN D DEFICIENCY 1 0.0001
269 VITREOUS FLOATERS 1 0.0001
270 LIGAMENT SPRAIN 1 0.0001
271 SINUS DISORDER 2 0.0001
272 PRODUCT ADMINISTRATION ERROR 2 0.0001
273 DRUG LEVEL DECREASED 1 0.0001
274 TOOTH ABSCESS 1 0.0001
275 SLUGGISHNESS 1 0.0001
276 TEMPERATURE INTOLERANCE 1 0.0001
277 SKELETAL INJURY 1 0.0001
278 EYE DISCHARGE 1 0.0001
279 WEIGHT FLUCTUATION 1 0.0001
280 INCONTINENCE 1 0.0001
281 JOINT DISLOCATION 1 0.0001
282 RENAL PAIN 1 0.0001
283 DEATH 81 0.0001
284 BREAST PAIN 1 0.0001
285 BREAST CANCER METASTATIC 1 0.0001
286 RHINORRHOEA 6 0.0001
287 ACNE 7 0.0001
288 SKIN LACERATION 1 0.0001
289 PULMONARY THROMBOSIS 1 0.0001
290 OESOPHAGITIS 1 0.0001
291 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
292 INJECTION SITE NODULE 1 0.0001
293 TOOTH FRACTURE 1 0.0001
294 ANGIOEDEMA 4 0.0001
295 EYE INFECTION 1 0.0001
296 APPLICATION SITE PRURITUS 2 0.0001
297 IMPAIRED DRIVING ABILITY 1 0.0001
298 MICTURITION URGENCY 1 0.0001
299 NEPHROLITHIASIS 4 0.0001
300 LETHARGY 5 0.0001
301 HYPOKALAEMIA 4 0.0001
302 MADAROSIS 1 0.0001
303 VASCULITIS 1 0.0001
304 RASH MACULAR 3 0.0001
305 DYSPHONIA 5 0.0001
306 ATAXIA 1 0.0001
307 MYOCLONUS 1 0.0001
308 SKIN BURNING SENSATION 6 0.0001
309 HYPERLIPIDAEMIA 1 0.0001
310 POLYNEUROPATHY 1 0.0001
311 PANIC ATTACK 3 0.0001
312 RESTLESSNESS 3 0.0001
313 ENCEPHALOPATHY 2 0.0001
314 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
315 ABASIA 2 0.0001
316 CYST 1 0.0001
317 APPLICATION SITE IRRITATION 1 0.0001
318 HOT FLUSH 6 0.0001
319 FLUSHING 8 0.0001
320 FLUID RETENTION 4 0.0001
321 INJECTION SITE IRRITATION 1 0.0001
322 MYDRIASIS 1 0.0001
323 SPEECH DISORDER 4 0.0001
324 HAND DEFORMITY 1 0.0001
325 ORAL CANDIDIASIS 1 0.0001
326 IMMUNE SYSTEM DISORDER 1 0.0001
327 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
328 ABNORMAL BEHAVIOUR 3 0.0001
329 BRADYCARDIA 4 0.0001
330 INJECTION SITE PRURITUS 5 0.0001
331 SINUS CONGESTION 1 0.0001
332 NEUROPATHY PERIPHERAL 7 0.0001
333 OSTEOPOROSIS 3 0.0001
334 CORONARY ARTERY OCCLUSION 1 0.0001
335 ABNORMAL DREAMS 2 0.0001
336 ARTHROPATHY 4 0.0001
337 ORAL DISCOMFORT 1 0.0001
338 FEELING COLD 2 0.0001
339 HYPOMAGNESAEMIA 1 0.0001
340 HAEMOPTYSIS 2 0.0001
341 COORDINATION ABNORMAL 1 0.0001
342 MASS 1 0.0001
343 CARPAL TUNNEL SYNDROME 1 0.0001
344 OSTEOARTHRITIS 3 0.0001
345 PAIN IN JAW 2 0.0001
346 HEPATOCELLULAR INJURY 1 0.0001
347 SINUS TACHYCARDIA 1 0.0001
348 PARAESTHESIA 11 0.0001
349 SUBDURAL HAEMATOMA 1 0.0001
350 PSORIASIS 9 0.0001
351 LABORATORY TEST ABNORMAL 2 0.0001
352 WHEEZING 4 0.0001
353 IMMUNODEFICIENCY 1 0.0001
354 ANXIETY 19 0.0001
355 HYPOAESTHESIA ORAL 1 0.0001
356 APHASIA 2 0.0001
357 DEVICE FAILURE 1 0.0001
358 URTICARIA 11 0.0001
359 DISCOMFORT 4 0.0001
360 MUSCLE SPASMS 12 0.0001
361 INJECTION SITE RASH 2 0.0001
362 DRUG ADMINISTRATION ERROR 2 0.0001
363 THYROID DISORDER 1 0.0001
364 LYMPHOMA 1 0.0001
365 LIMB DISCOMFORT 2 0.0001
366 ANKLE FRACTURE 1 0.0001
367 DELUSION 1 0.0001
368 COGNITIVE DISORDER 3 0.0001
369 BASAL CELL CARCINOMA 1 0.0001
370 SWOLLEN TONGUE 2 0.0001
371 PRODUCT USE COMPLAINT 1 0.0001
372 HEAD INJURY 2 0.0001
373 RESPIRATORY TRACT CONGESTION 1 0.0001
374 SCIATICA 1 0.0001
375 METABOLIC ACIDOSIS 2 0.0001
376 SENSORY DISTURBANCE 1 0.0001
377 HIP FRACTURE 2 0.0001
378 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
379 MUSCULAR WEAKNESS 7 0.0001
380 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
381 COAGULOPATHY 1 0.0001
382 DEHYDRATION 8 0.0001
383 GAIT INABILITY 2 0.0001
384 FACE OEDEMA 1 0.0001
385 ANGER 2 0.0001
386 HEMIPARESIS 1 0.0001
387 BLOOD PRESSURE INCREASED 9 0.0001
388 METRORRHAGIA 1 0.0001
389 FEELING ABNORMAL 14 0.0001
390 PARANOIA 1 0.0001
391 DELIRIUM 2 0.0001
392 LOCAL SWELLING 1 0.0001
393 MUSCULOSKELETAL PAIN 3 0.0001
394 EOSINOPHILIA 1 0.0001
395 METASTASES TO LIVER 1 0.0001
396 SLEEP DISORDER 4 0.0001
397 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
398 LYMPHADENOPATHY 2 0.0001
399 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
400 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
401 PELVIC PAIN 1 0.0001
402 RESTLESS LEGS SYNDROME 1 0.0001
403 TREATMENT NONCOMPLIANCE 3 0.0001
404 SOMNOLENCE 11 0.0001
405 NASOPHARYNGITIS 10 0.0001
406 BRONCHITIS 4 0.0001
407 OROPHARYNGEAL PAIN 5 0.0001
408 HYPERSENSITIVITY 10 0.0001
409 HEPATIC STEATOSIS 1 0.0001
410 WEIGHT INCREASED 12 0.0001
411 COUGH 15 0.0001
412 SWELLING 5 0.0001
413 DYSARTHRIA 2 0.0001
414 DYSPNOEA EXERTIONAL 2 0.0001
415 HALLUCINATION 4 0.0001
416 BLOOD URINE PRESENT 1 0.0001
417 HERPES ZOSTER 3 0.0001
418 EYE IRRITATION 3 0.0001
419 POST PROCEDURAL COMPLICATION 1 0.0001
420 PRURITUS 20 0.0001
421 GLAUCOMA 1 0.0001
422 CHILLS 6 0.0001
423 PAIN IN EXTREMITY 15 0.0001
424 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
425 BLOOD PRESSURE ABNORMAL 1 0.0001
426 IRRITABILITY 3 0.0000
427 DRY MOUTH 4 0.0000
428 PSORIATIC ARTHROPATHY 2 0.0000
429 OEDEMA PERIPHERAL 6 0.0000
430 VERTIGO 3 0.0000
431 BONE MARROW FAILURE 1 0.0000
432 CHEST DISCOMFORT 5 0.0000
433 POLLAKIURIA 2 0.0000
434 MALAISE 21 0.0000
435 SKIN EXFOLIATION 4 0.0000
436 HALLUCINATION, VISUAL 1 0.0000
437 EATING DISORDER 1 0.0000
438 RETCHING 1 0.0000
439 URINARY TRACT INFECTION 8 0.0000
440 JOINT INJURY 1 0.0000
441 HYPOAESTHESIA 7 0.0000
442 IRRITABLE BOWEL SYNDROME 1 0.0000
443 LIVER FUNCTION TEST INCREASED 1 0.0000
444 HYPERHIDROSIS 6 0.0000
445 RECTAL HAEMORRHAGE 2 0.0000
446 BALANCE DISORDER 4 0.0000
447 PRURITUS GENERALISED 1 0.0000
448 SWELLING FACE 3 0.0000
449 CONSTIPATION 10 0.0000
450 INSOMNIA 12 0.0000
451 RASH MACULO-PAPULAR 1 0.0000
452 HEPATOTOXICITY 1 0.0000
453 GLOSSODYNIA 1 0.0000
454 SNEEZING 1 0.0000
455 DEPRESSION 10 0.0000
456 PRODUCT AVAILABILITY ISSUE 1 0.0000
457 ABDOMINAL PAIN UPPER 9 0.0000
458 VISION BLURRED 6 0.0000
459 INJECTION SITE REACTION 3 0.0000
460 RASH 19 0.0000
461 TINNITUS 2 0.0000
462 MUSCLE TWITCHING 1 0.0000
463 CONFUSIONAL STATE 7 0.0000
464 ARTHRALGIA 18 0.0000
465 RENAL DISORDER 2 0.0000
466 CONDITION AGGRAVATED 13 0.0000
467 ASTHENIA 16 0.0000
468 TREMOR 7 0.0000
469 DYSPHAGIA 4 0.0000
470 FALL 14 0.0000
471 COMA 2 0.0000
472 LOCALISED INFECTION 1 0.0000
473 HYPOGLYCAEMIA 2 0.0000
474 PRESYNCOPE 1 0.0000
475 PAIN 25 0.0000
476 DYSPEPSIA 4 0.0000
477 NAUSEA 32 0.0000
478 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
479 AGEUSIA 1 0.0000
480 PNEUMONIA ASPIRATION 1 0.0000
481 UNEVALUABLE EVENT 3 0.0000
482 ABDOMINAL PAIN LOWER 1 0.0000
483 HAEMATEMESIS 1 0.0000
484 THERAPY CESSATION 2 0.0000
485 ERYTHEMA 8 0.0000
486 DIARRHOEA 25 0.0000
487 SKIN ULCER 1 0.0000
488 RESPIRATORY TRACT INFECTION 1 0.0000
489 NERVOUSNESS 2 0.0000
490 GASTRITIS 1 0.0000
491 HYPERTENSION 8 0.0000
492 EAR INFECTION 1 0.0000
493 PYREXIA 13 0.0000
494 INJECTION SITE HAEMORRHAGE 3 0.0000
495 PLATELET COUNT DECREASED 4 0.0000
496 DRY SKIN 5 0.0000
497 MENSTRUATION IRREGULAR 1 0.0000
498 THROMBOSIS 3 0.0000
499 FEAR 1 0.0000
500 DRUG EFFECT DECREASED 2 0.0000
501 DISTURBANCE IN ATTENTION 2 0.0000
502 OVERDOSE 8 0.0000
503 PALLOR 1 0.0000
504 HEADACHE 23 0.0000
505 GAIT DISTURBANCE 7 0.0000
506 INFLUENZA LIKE ILLNESS 3 0.0000
507 MEMORY IMPAIRMENT 5 0.0000
508 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
509 INFLUENZA 4 0.0000
510 SEPSIS 4 0.0000
511 ABDOMINAL DISCOMFORT 6 0.0000
512 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
513 RED BLOOD CELL COUNT DECREASED 1 0.0000
514 SEIZURE 4 0.0000
515 BACK PAIN 8 0.0000
516 LIVER FUNCTION TEST ABNORMAL 1 0.0000
517 URINARY INCONTINENCE 1 0.0000
518 DYSPNOEA 19 0.0000
519 BLOOD POTASSIUM DECREASED 1 0.0000
520 LACRIMATION INCREASED 1 0.0000
521 CORONARY ARTERY DISEASE 1 0.0000
522 THERAPEUTIC RESPONSE DECREASED 2 0.0000
523 SUICIDE ATTEMPT 2 0.0000
524 EPILEPSY 1 0.0000
525 INJECTION SITE PAIN 10 0.0000
526 PERIPHERAL SWELLING 5 0.0000
527 CYSTITIS 1 0.0000
528 MOOD SWINGS 1 0.0000
529 HYPOTHYROIDISM 1 0.0000
530 MOVEMENT DISORDER 1 0.0000
531 FATIGUE 24 0.0000
532 DEEP VEIN THROMBOSIS 2 0.0000
533 PRODUCT DOSE OMISSION 2 0.0000
534 BLOOD CREATININE INCREASED 2 0.0000
535 OSTEONECROSIS 1 0.0000
536 STAPHYLOCOCCAL INFECTION 1 0.0000
537 DECREASED APPETITE 7 0.0000
538 BLOOD PRESSURE DECREASED 2 0.0000
539 DIZZINESS 15 0.0000
540 LIP SWELLING 1 0.0000
541 FUNGAL INFECTION 1 0.0000
542 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
543 HEPATIC ENZYME INCREASED 2 0.0000
544 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
545 GASTRIC DISORDER 1 0.0000
546 DEVICE USE ERROR 1 0.0000
547 WEIGHT DECREASED 8 0.0000
548 BURNING SENSATION 2 0.0000
549 HYPERKALAEMIA 1 0.0000
550 PRODUCT ADHESION ISSUE 1 0.0000
551 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
552 VOMITING 13 0.0000
553 CRYING 1 0.0000
554 CHEST PAIN 5 0.0000
555 EYE SWELLING 1 0.0000
556 HEPATIC FUNCTION ABNORMAL 1 0.0000
557 BLOOD GLUCOSE INCREASED 5 0.0000
558 COLITIS 1 0.0000
559 INJECTION SITE BRUISING 2 0.0000
560 JOINT SWELLING 3 0.0000
561 PNEUMONIA 8 0.0000
562 EXTRA DOSE ADMINISTERED 1 0.0000
563 BLINDNESS 1 0.0000
564 CARDIAC ARREST 2 0.0000
565 VISUAL IMPAIRMENT 3 0.0000
566 DRUG DOSE OMISSION 4 0.0000
567 WITHDRAWAL SYNDROME 1 0.0000
568 RENAL FAILURE ACUTE 1 0.0000
569 LOSS OF CONSCIOUSNESS 3 0.0000
570 MENTAL DISORDER 1 0.0000
571 DRUG WITHDRAWAL SYNDROME 2 0.0000
572 DRUG INEFFECTIVE 30 0.0000
573 LIVER DISORDER 1 0.0000
574 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
575 COLITIS ULCERATIVE 1 0.0000
576 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
577 GASTROINTESTINAL DISORDER 2 0.0000
578 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
579 PRODUCT QUALITY ISSUE 3 0.0000
580 SUICIDAL IDEATION 2 0.0000
581 BLOOD CHOLESTEROL INCREASED 1 0.0000
582 DISEASE RECURRENCE 1 0.0000
583 ANAEMIA 4 0.0000
584 PRODUCTIVE COUGH 1 0.0000
585 MULTIPLE SCLEROSIS 1 0.0000
586 INFECTION 3 0.0000
587 ATRIAL FIBRILLATION 2 0.0000
588 LUNG DISORDER 1 0.0000
589 CELLULITIS 1 0.0000
590 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
591 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
592 ECZEMA 1 0.0000
593 DEPRESSED MOOD 1 0.0000
594 DRUG INTERACTION 3 0.0000
595 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
596 RASH PRURITIC 1 0.0000
597 OEDEMA 1 0.0000
598 DEPENDENCE 1 0.0000
599 ANAPHYLACTIC REACTION 1 0.0000
600 PANCYTOPENIA 1 0.0000
601 NECK PAIN 1 0.0000
602 THROMBOCYTOPENIA 2 0.0000
603 BLISTER 1 0.0000
604 HYPONATRAEMIA 1 0.0000
605 MYALGIA 3 0.0000
606 FLATULENCE 1 0.0000
607 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
608 MYOCARDIAL INFARCTION 3 0.0000
609 ABDOMINAL PAIN 4 0.0000
610 BONE PAIN 1 0.0000
611 SURGERY 1 0.0000
612 CATARACT 1 0.0000
613 EMOTIONAL DISTRESS 2 0.0000
614 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
615 INJECTION SITE ERYTHEMA 2 0.0000
616 INTENTIONAL OVERDOSE 1 0.0000
617 AMNESIA 1 0.0000
618 INFUSION RELATED REACTION 1 0.0000
619 FEBRILE NEUTROPENIA 1 0.0000
620 HYPOTENSION 3 0.0000
621 NEUTROPENIA 2 0.0000
622 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
623 MOBILITY DECREASED 1 0.0000
624 OFF LABEL USE 12 0.0000
625 AGITATION 1 0.0000
626 DYSGEUSIA 1 0.0000
627 CHRONIC KIDNEY DISEASE 1 0.0000
628 INJECTION SITE SWELLING 1 0.0000
629 HOSPITALISATION 2 0.0000
630 ARTHRITIS 1 0.0000
631 DRUG DEPENDENCE 2 0.0000
632 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
633 TREATMENT FAILURE 1 0.0000
634 COMPLETED SUICIDE 1 0.0000
635 TOXICITY TO VARIOUS AGENTS 2 0.0000
636 CEREBROVASCULAR ACCIDENT 2 0.0000
637 INTENTIONAL PRODUCT MISUSE 1 0.0000
638 TACHYCARDIA 1 0.0000
639 NO ADVERSE EVENT 2 0.0000
640 BREAST CANCER 1 0.0000
641 PRODUCT USE ISSUE 2 0.0000
642 PULMONARY EMBOLISM 1 0.0000
643 CONTUSION 1 0.0000
644 DRUG INTOLERANCE 1 0.0000
645 PRODUCT DOSE OMISSION ISSUE 3 0.0000
646 ALOPECIA 2 0.0000
647 SYNCOPE 1 0.0000
648 HAEMOGLOBIN DECREASED 1 0.0000
649 ILLNESS 1 0.0000
650 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
651 HAEMORRHAGE 1 0.0000
652 DISEASE PROGRESSION 1 0.0000
653 RENAL FAILURE 1 0.0000
654 ACUTE KIDNEY INJURY 1 0.0000
655 INCORRECT DOSE ADMINISTERED 1 0.0000